(90 days)
The BLUNTPORT™ Blunt Trocar with Threaded Anchor is intended for use in a variety of gynecologic, general, thoracic, and urologic endoscopic procedures to create and maintain a port of entry.
The Bluntport™ with Threaded Anchor 5mm-12mm is a sterile. single use device used for abdominal access during laparoscopic procedures. The device consists of a cannula assembly, blunttipped obturator component and an anchoring assembly. The cannula assembly accommodates various size laparoscopic devices ranging from 5mm to 12mm in diameter while still maintaining pneumoperitoneum. The anchoring device provides stability of the cannula at the access site.
The provided document is a 510(k) summary for the Covidien Bluntport™ Blunt Trocar with Threaded Anchor 5mm-12mm. It outlines the device description, intended use, and a comparison with a predicate device. However, it does not provide detailed acceptance criteria and specific performance results in a quantifiable manner from a study.
The document states that "Design verification studies were conducted to demonstrate that the Bluntport™ with Threaded Anchor 5mm-12mm is safe and effective and performs as intended." It then lists the types of tests performed. For this type of device (a surgical trocar), the "acceptance criteria" are typically related to the functional performance of the device (e.g., maintaining pneumoperitoneum, anchoring strength, biocompatibility), and the "study" would involve testing the device against these performance requirements.
Based on the provided text, I can infer the general categories of acceptance criteria and the types of studies conducted, but I cannot give specific numerical acceptance thresholds or the detailed performance data that would "prove" the device meets them. The 510(k) summary focuses on demonstrating substantial equivalence to a predicate device rather than providing a detailed clinical study report with specific statistical outcomes.
Here's an attempt to structure the information based on what is available and what is typically expected for such devices, while acknowledging the limitations of the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Expected Performance (Inferred) | Reported Device Performance (as stated in document) |
|---|---|---|
| Pneumoperitoneum Leak Rate | Device should prevent significant gas leakage during use to maintain surgical cavity inflation. | Studies conducted for "pneumoperitoneum leak rate" (details not provided, but implies satisfactory performance). |
| Anchoring Strength | Device should remain securely anchored at the access site without dislodgement during procedures. | Studies conducted for "anchoring strength" (details not provided, but implies satisfactory performance). |
| Anchor Position Adjustment | The anchoring mechanism should allow for appropriate and secure adjustment as intended. | Studies conducted for "anchor position adjustment" (details not provided, but implies satisfactory performance). |
| Biocompatibility (Cytotoxicity) | Device materials should not cause cytotoxic reactions. | Studies conducted for "cytotoxicity" (implies passing standard biocompatibility tests). |
| Biocompatibility (Sensitization) | Device materials should not cause sensitization (allergic reactions). | Studies conducted for "sensitization" (implies passing standard biocompatibility tests). |
| Biocompatibility (Intracutaneous Irritation) | Device materials should not cause significant skin irritation upon contact. | Studies conducted for "intracutaneous irritation" (implies passing standard biocompatibility tests). |
| Biocompatibility (Acute Systemic Toxicity) | Device materials should not cause acute systemic toxic effects. | Studies conducted for "acute systemic toxicity" (implies passing standard biocompatibility tests). |
| Overall Safety & Effectiveness | The device should be safe and effective for its intended use and comparable to predicate device. | "Design verification studies were conducted to demonstrate that the Bluntport™... is safe and effective and performs as intended." |
| Substantial Equivalence | The device should be substantially equivalent to the predicate device and not introduce new risks. | "The result of these tests demonstrate that the Bluntport™... is substantially equivalent to the predicate device and does not introduce additional risk to the patient." |
Limitations: The document only lists the types of tests performed. It does not provide specific numerical acceptance criteria (e.g., "leak rate less than X mL/min") or the quantitative results of these tests. The statement "implies satisfactory performance" is an interpretation based on the conclusion that the device is safe, effective, and substantially equivalent.
2. Sample Size Used for the Test Set and Data Provenance
The document does not specify the sample sizes used for any of the listed tests (pneumoperitoneum leak rate, anchoring strength, etc.).
The data provenance is not explicitly stated (e.g., country of origin). The studies appear to be retrospective in the sense that they are design verification studies performed by the manufacturer, rather than prospective clinical trials.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications
For a device like a surgical trocar, "ground truth" and "experts" as typically understood in diagnostic AI/image analysis studies are not directly applicable in the same way. The performance of the device (e.g., leak rate, anchoring strength) is typically measured using engineering and biological testing methods against established standards or internal specifications, not by expert consensus on clinical findings. Therefore, this information is not provided and is likely not relevant in the context of this device's verification.
4. Adjudication Method for the Test Set
As explained above, "adjudication method" is not applicable here, as these are technical performance and biocompatibility tests rather than assessments requiring human interpretation of data for ground truth.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No. A Multi-Reader Multi-Case (MRMC) comparative effectiveness study is designed for evaluating diagnostic devices or AI algorithms where human readers interpret medical data. This type of study is not applicable to a surgical tool like a trocar, and therefore, no such study or its effect size is mentioned.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
No. This question refers to the performance of an AI algorithm independent of human interaction. The Covidien Bluntport™ Blunt Trocar is a physical surgical device, not an AI algorithm. Therefore, a standalone performance study in this context is not applicable.
7. Type of Ground Truth Used
The "ground truth" for the performance tests (e.g., pneumatic leak rate, anchoring strength) would be objective physical measurements obtained through standardized engineering and laboratory testing protocols. For biocompatibility, the ground truth would be established by the results of standardized biological assays (e.g., cell viability, immune response indicators) interpreted against established ISO standards (ISO 10993-1).
8. Sample Size for the Training Set
Not Applicable. The device is a physical surgical tool, not an AI algorithm that requires a "training set" of data.
9. How the Ground Truth for the Training Set Was Established
Not Applicable. As there is no training set for a physical surgical device, this question is not relevant.
{0}------------------------------------------------
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 9, 2014
Covidien % Ms. Mary Mellows Senior Regulatory Specialist 60 Middletown Avenue North Haven, Connecticut 06473
Re: K142547
Trade/Device Name: Bluntport Blunt Trocar with Threaded Anchor 5mm-12mm Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: Class II Product Code: GCJ Dated: November 7, 2014 Received: November 10, 2014
Dear Ms. Mellows:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
{1}------------------------------------------------
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
David Krause -S
- Binita S. Ashar, M.D., M.B.A., F.A.C.S. for Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K142547
Device Name
Bluntport™ Blunt Trocar with Threaded Anchor 5mm-12mm
Indications for Use (Describe)
The BLUNTPORT™ Blunt Trocar with Threaded Anchor is intended for use in a variety of gynecologic, general, thoracic, and urologic endoscopic procedures to create and maintain a port of entry.
Type of Use (Select one or both, as applicable)
2 Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Covidien. The logo consists of a blue square with a white plus sign in the center, followed by the word "COVIDIEN" in blue, sans-serif font. The plus sign is made up of several smaller squares of varying shades of blue and white.
510(k) Summary
This 510(k) summary information is submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990. The contents of the 510(k) summary have been provided in conformance with 21 CFR §807.92.
| SUBMITTER: | Covidien60 Middletown AvenueNorth Haven, CT 06473(203) 492-5284 (T) |
|---|---|
| CONTACT PERSON: | Mary MellowsSenior Specialist, Regulatory Affairs |
| DATE PREPARED: | November 7, 2014 |
| TRADE/PROPRIETRY NAME: | Bluntport™ Blunt Trocar with Threaded Anchor 5mm-12mm |
| COMMON/USUAL NAME: | Surgical Trocar |
| CLASSIFICATION NAME: | Endoscope and Accessories |
| FDA PANEL NUMBER: | 78 |
| PRODUCT CODE: | GCJ |
| CLASS CODE: | Pursuant to 21 CFR 876.1500, surgical trocar is a Class IIdevice |
| LEGALLY MARKETEDDEVICES TO WHICHEQUIVALENCY ISCLAIMED: | Versaport™ V2 Bladeless Optical Trocar (K130435) |
CONFIDENTIAL
Special 510(k) Bluntport™ Blunt Trocar with Threaded Anchor 5mm-12mm
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the logo for Covidien. The logo consists of a blue square with a white square in the center and a light blue vertical line running through the center of the white square. To the right of the square is the word "COVIDIEN" in a dark blue sans-serif font.
REFERENCED DEVICES NOTED IN THIS SUBMISSION:
Auto Suture™ Modified Grip (K942885) Endo GIA Radial Reload (K132493) SILS Hand Instruments (K091869)
REASON FOR 510(K) SUBMISSION:
Obtain market clearance for Covidien's Bluntport™ Blunt Trocar with Threaded Anchor 5mm-12mm.
DEVICE DESCRIPTION: The Bluntport™ with Threaded Anchor 5mm-12mm is a sterile. single use device used for abdominal access during laparoscopic procedures. The device consists of a cannula assembly, blunttipped obturator component and an anchoring assembly. The cannula assembly accommodates various size laparoscopic devices ranging from 5mm to 12mm in diameter while still maintaining pneumoperitoneum. The anchoring device provides stability of the cannula at the access site.
INTENDED USE: Intended for use in a variety of gynecologic, general, thoracic, and urologic endoscopic procedures to create and maintain a port of entry.
TECHNICAL
CHARACTERISTICS:
Bluntport™ with Threaded Anchor 5mm-12mm The is substantially equivalent and has not introduced any new features relative to the predicate or referenced devices. An anchoring assembly (K942885) has been incorporated to secure the cannula assembly against tissue.
| Bluntport™ Blunt Trocarwith Threaded Anchor5mm-12mm(Proposed Device) | Predicate Versaport™ V2Bladeless Optical Trocar(K130435) | |
|---|---|---|
| Technological/Design Characteristics | Cannula AssemblySleeve:Smooth | Cannula AssemblySleeve:Smooth or Ribbed |
| Housing:Internal seal | Housing:Same as proposed device | |
| Obturator Component:Blunt-tipped darkblue acrylonitrile butadienestyrene (ABS) with solidproximal and distal ends | Obturator Component:Bladeless 304 Stainless Steeland dark blue ABS withtransparent window at distalend and scope retentionmember at proximal opening. | |
| Anchoring Device:White ABS housing withdark blue nylon screw | Anchoring Assembly:None |
CONFIDENTIAL
Special 510(k) Bluntport™ Blunt Trocar with Threaded Anchor 5mm-12mm
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image contains the logo for Covidien. The logo consists of a blue square with a white square inside, and a blue vertical line running through the center. To the right of the square is the word "COVIDIEN" in blue, sans-serif font. The logo is simple and modern, and the colors are clean and professional.
- MATERIALS: All components of the blunt-tipped obturator component and cannula assembly are similar to the predicate device Versaport™ V2 Bladeless Optical Trocar (K130435). Components of the anchoring assembly are similar to the Auto Suture™ Modified Grip (K942885) and materials used in the anchoring assembly are also used in the Endo GIA Radial Reload (K132493) and the SILS Hand Instruments (K091869). All materials have been tested in accordance with ISO Standard 10993-1.
- Design verification studies were conducted to demonstrate that PERFORMANCE DATA: the Bluntport™ with Threaded Anchor 5mm-12mm is safe and effective and performs as intended. Testing to support the intended use of this device includes:
- In Vitro ●
- pneumoperitoneum leak rate o
- o anchoring strength
- anchor position adjustment O
- Biocompatibility ●
- cvtoxicity o
- sensitization O
- O intracutaneous Irritation
- acute Systemic Toxicity o
- In Vitro ●
- CONCLUSION: The result of these tests demonstrate that the Bluntport™ with Threaded Anchor 5mm-12mm is substantially equivalent to the predicate device and does not introduce additional risk to the patient.
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.